Literature DB >> 8706194

Sublingual triazolam versus peroral diazepam as a premedication for general anaesthesia.

H J Penttilä1, L S Nuutinen, K T Kiviluoma, A M Partanen.   

Abstract

Sublingual triazolam 0.2 mg (T) was compared with peroral diazepam 10 mg (D) as a premedicant in a randomised, double-blind study. Eighty-one ASA I-III patients aged 18-70 yr, scheduled for elective surgery and general anaesthesia were studied. The patients were premedicated about one hour preoperatively. The T-group subjects (n = 41) received triazolam sl after a placebo po and the D-group subjects (n = 40) diazepam po before a sl placebo. Anxiety and sedation were evaluated before premedication, every 15 min after that until the patient was removed to the operating room, just before the induction of anaesthesia and both 30 and 60 min after operation. Anxiety and sedation were evaluated by the patient using a visual analogue scale (VAS) and by the anaesthetist with a scale of 0-3 for anxiety and 0-4 for sedation. The patients' experience with regards to their premedication and visit to the operating unit were investigated after the operation. In both groups sedation and anxiolysis became different at 30-45 min after premedication, but at the time just before the induction of anaesthesia there was sedation and anxiolysis only in the T-group. There was no difference between the groups at any time. The T-group patients were more satisfied with their premedication and visit to the operating unit. The study drugs did not cause any cardiorespiratory or other side effects. We conclude that triazolam 0.2 mg sl is at least as effective a premedication as diazepam 10 mg po, that is suitable for patients that cannot swallow, and that the patients were more satisfied with it than with diazepam.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8706194     DOI: 10.1007/BF03011032

Source DB:  PubMed          Journal:  Can J Anaesth        ISSN: 0832-610X            Impact factor:   5.063


  14 in total

1.  [Sedation in ambulatory minor oral surgery: sublingual triazolam].

Authors:  G Manani; R Blasone; L Cirillo; G Vidoni; P La Rosa; L Franceschini; R Ricci; M Meroni; G P Giron
Journal:  G Anest Stomatol       Date:  1989 Oct-Dec

2.  Behavioural reactions to triazolam.

Authors:  N MacLeod; C H Kratochvil
Journal:  Lancet       Date:  1979-09-22       Impact factor: 79.321

3.  Enhanced bioavailability of triazolam following sublingual versus oral administration.

Authors:  J M Scavone; D J Greenblatt; H Friedman; R I Shader
Journal:  J Clin Pharmacol       Date:  1986-03       Impact factor: 3.126

Review 4.  Pharmacologic and clinical aspects of preoperative medication.

Authors:  P F White
Journal:  Anesth Analg       Date:  1986-09       Impact factor: 5.108

5.  [Premedication with triazolam].

Authors:  H Smonig; K H Glaser; H Höfler
Journal:  Anasth Intensivther Notfallmed       Date:  1990-01

6.  Effectiveness of triazolam, diazepam, and placebo as preanesthetic medications.

Authors:  V L Baughman; G L Becker; C M Ryan; M Glaser; J P Abenstein
Journal:  Anesthesiology       Date:  1989-08       Impact factor: 7.892

7.  Premedication with sublingual triazolam compared with oral diazepam.

Authors:  V K Kontinen; E L Maunuksela; J Sarvela
Journal:  Can J Anaesth       Date:  1993-09       Impact factor: 5.063

8.  Placebo controlled comparison of midazolam, triazolam and diazepam as oral premedicants for outpatient anaesthesia.

Authors:  P Forrest; D C Galletly; P Yee
Journal:  Anaesth Intensive Care       Date:  1987-08       Impact factor: 1.669

9.  Experience with triazolam as a preoperative sedative for outpatient surgery under local anesthesia.

Authors:  R Riefkohl; R Kosanin
Journal:  Aesthetic Plast Surg       Date:  1984       Impact factor: 2.326

10.  The Halcion story: trial by media.

Authors:  L Lasagna
Journal:  Lancet       Date:  1980-04-12       Impact factor: 79.321

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.